External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ACR 2025
Roche and Genentech at

ACR 2025

October 24 - October 29
Chicago, USA / Virtual (Hybrid)
rheumatology.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
03:30 PM
Duration 120mins Chicago, USA
Obinutuzumab Shows Promise in Lupus Nephritis Regardless of Baseline Serological Markers: An Exploratory Post Hoc Analysis of a Phase II Trial
Edward M. Vital, Benni Vargas, Julie Rae, Tracey Wang, Jason Hackney, Cary M. Looney, William F. Pendergraft III, Liz Lightstone, Brad H. Rovin, Richard A. Furie, Harini Raghu
Nephrology - Rheumatology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Chicago, USA
Infusion-Related Reactions (IRRs) and Hematologic Events Associated With Obinutuzumab in Lupus Nephritis: A Secondary Analysis of a Phase III Trial
Richard A. Furie,Teresa Baczkowska, Amit Saxena, Imran Hassan, Bongin Yoo, Ben Lanza, Himanshi Sehgal, Frederic Boissard, Jay P. Garg, Thomas Schindler, Elsa Martins, William F. Pendergraft, Brad H. Rovin
Nephrology - Rheumatology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Chicago, USA
Pharmacodynamic Effects of Obinutuzumab on B cells and Serological Markers in Patients With Active Lupus Nephritis: Results From a Phase III Trial
Richard A. Furie, Ioannis Parodis, Rachel Jones, Liz Lightstone, Olivia Hwang, Amelia Au-Yeung, Imran Hassan, Huiyan (Ashley) Mao, William F. Pendergraft III, Jay P. Garg, Harini Raghu, Brad H. Rovin
Nephrology - Rheumatology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Chicago, USA
Obinutuzumab Demonstrates Steroid-Sparing Effects and Consistent Benefit In Patients With Lupus Nephritis When Using Multiple Primary Endpoint Definitions: A Secondary Analysis of Phase III Trial Results
Brad H. Rovin, Jay P. Garg, Richard A. Furie, Rachel Jones, Amit Saxena, Pasquale Esposito, Fedra Irazoque Palazuelos, Elsa Martins, Claire Petry, Nicolas Frey, Bongin Yoo, Imran Hassan, Thomas Schindler, Theodore A. Omachi, William F. Pendergraft, Mittermayer B. Santiago, Gustavo Aroca-Martínez, Ana Malvar
Nephrology - Rheumatology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:15 PM
Duration 15mins Chicago
Complete Renal Response and Long-Term, Progression-Free Survival in Adult Patients with Lupus Nephritis: A Retrospective Cohort Study in the United States
Lisa Lindsay, Shu Wang, Huong Trinh, Yunru (Claire) Huang, William F. Pendergraft III, Brad H. Rovin
Nephrology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:30 PM
Duration 120mins Chicago, USA
Obinutuzumab Leads to Deep B-Cell Depletion in the Kidney Parenchyma of Patients With Lupus Nephritis: An Exploratory Analysis of the REGENCY Trial
Brad H. Rovin, Elsa Martins, Cary D. Austin, Harini Raghu, Caleb Chan, Patrick S. Chang, Jay P. Garg, Valeria Alberton, Mittermayer B. Santiago, Gustavo Aroca-Martínez, Fedra I. Palazuelos, Teresa Baczkowska, José Alfaro, Jorge Ravelo-Hernández, Richard A. Furie, Luís F. Pinto, Eduardo H. Albiero, Christopher Larsen, Bongin Yoo, Jennifer Pulley, Andrew Thorley, Thomas Schindler, Theodore A. Omachi, William F. Pendergraft III, Ana Malvar
Nephrology - Rheumatology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:30 PM
Duration 120mins Chicago, USA
Kidney-Related Outcomes With Obinutuzumab in Patients With Active Lupus Nephritis: A Pre-Specified Exploratory Analysis of the Clinical Trial Data
Brad H. Rovin, William F. Pendergraft III, Liz Lightstone, Eric Daugas, Richard A. Furie, Theodore A. Omachi, Imran Hassan, Elsa Martins, Thomas Schindler, Jay P. Garg, Luis F. Quintana, Piotr Leszczyński, Ana Malvar
Nephrology - Rheumatology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Chicago, USA
Real-World Immunosuppressant Treatment Patterns In Lupus Nephritis: A Retrospective Claims Database Analysis In The United States
Anisha M. Patel, Alexandra Miller, Lisa Lindsay, Danny Sheinson, Zhiyu Xia, William F. Pendergraft III, Maria Dall'Era
Nephrology - Rheumatology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.